#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Oesophageal squamous cell carcinoma stage II Leukaemia Osteochondrodysplasia Juvenile psoriatic arthritis Rhabdomyosarcoma Frontotemporal dementia Hormone-dependent prostate cancer Von Hippel-Lindau disease Hypotransferrinaemia Hypoxic-ischaemic encephalopathy Staphylococcal infection Neuroendocrine carcinoma metastatic Acute on chronic liver failure Hereditary optic atrophy Acute myeloid leukaemia More trials…

    Learn about Rare Diseases

    Sarcoma – Treatment Hepatic angiosarcoma – Diagnostics Haemophilia B without inhibitors – Diagnostics Haemophilia A with anti factor VIII – Treatment Progressive supranuclear palsy – Life with Disease Toxic epidermal necrolysis – Life with Disease Pelizaeus-Merzbacher disease – Life with Disease Adrenogenital syndrome – Trials in Disease Alport’s syndrome – Basic Information Skin angiosarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Demeclocycline Hydrochloride Rtp-026 Sodium Amiloride Hydrochloride NAVENIBART 1,3-BUTYLENE GLYCOL Cisatracurium Besilate Emiplacel Pantothenate Sodium Crizanlizumab Siltuximab Tabelecleucel Mbs2320 Carmustine Jnj-64042056 Carbidopa Cannabis Sativa Flower Lib-01 Monohydrate Daplusiran Sumatriptan Succinate Pehero More therapies…

    Learn about Your Condition

    Endocrine ophthalmopathy Oesophageal achalasia Fibrosarcoma Immune-mediated renal disorder Hypertrophic scar Polycythaemia vera Toxic epidermal necrolysis Anaemia of pregnancy Methylmalonic acidaemia Behavioural addiction Laryngeal cancer stage II Paget's disease of the vulva Biopsy heart Testicular germ cell cancer Hyperglycaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Testing rasburicase for preventing and treating kidney problems in adult patients with sepsis and high uric acid levels

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Sepsis
    Investigated Drugs:
    • Rasburicase
    France

  • Study comparing rocuronium dosing based on ideal versus real body weight for airway tube placement in patients with severe obesity

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Rocuronium Bromide
    • Propofol
    • Sodium Chloride
    Belgium

  • Testing UCPVax vaccine with or without pembrolizumab and temozolomide in patients with unmethylated MGMT glioblastoma after initial treatment

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • Ucp4
    • Temozolomide
    • Pembrolizumab
    France

  • A study on ketamine maintenance treatment for patients with treatment-resistant major depression disorder

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Depression
    • Major depression
    Investigated Drugs:
    • Ketamine Hydrochloride
    Norway

  • Study of pirtobrutinib combined with immuno-chemotherapy for previously untreated patients with symptomatic chronic lymphocytic leukemia

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Pirtobrutinib
    France

  • A Study of Mibavademab for Weight Loss in Children, Adolescents and Adults with Obesity Caused by LEP Gene Mutations

    Not yet recruiting

    3 1 1
    Germany
Previous Page
1 … 773 774 775 776 777 … 1,673
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!